Viral encephalitis remains a major public health problem in almost all the countries. Outbreaks of viral encephalitis have been reported to occur periodically in different parts of India. Various viruses like Japanese encephalitis, measles, herpes simplex virus and enteroviruses have been etiologically linked in various outbreaks of encephalitis. Japanese encephalitis is a major endemic virus in many parts of India including the state of Andhra Pradesh.

An epidemic of encephalitis was reported from the Andhra Pradesh state, India during June--September 2003 which was investigated in detail by National Institute of Virology (NIV), Pune to establish the etiologic agent \[[@B1]\]. The present study consists of retrospectively analysed data to describe clinical profile and assess the risk factors associated with fatality in this epidemic.

This study was carried out at the Government Institute of Child Health, Niloufer Hospital, Hyderabad, A.P, India where cases requiring specialist services were referred from all the affected districts of the state. Cases admitted with acute fever, altered sensorium and seizures were registered for study. Children with prior neurological disorders such as cerebral palsy, epilepsy, febrile convulsions and other CNS infections like Pyomeningitis, Tuberculous meningitis and Cerebral malaria were excluded. The final study group consisted of 104 patients.

For all these cases, clinical, epidemiological, treatment and outcome details were recorded in addition to laboratory data that included viral and serological studies.

The first symptom in these cases was fever with altered sensorium followed by seizures, diarrhoea and vomiting. Fever was continuous and its grade varied from low (102°F) to high grade (104°F) (41.3%) and subsided within 2--3 days from the onset in most of the cases (86.5%). Fever was immediately followed by altered sensorium; its severity varied from patient to patient. Glasgow score was ≤7 in 65.4% of the cases and \> 7 in 34.6% of the cases.

Seizures occurred during initial 1--3 days of illness. They were few and did not recur (GTCS 76.9%, Focal 23.1%).

Diarrhoea and vomiting were present (65.4%) during the first 24 h and were not severe enough to produce dehydration. Skin manifestations in the form of papular urticaria, mostly on exposed surfaces suggestive of insect bites were noticed in 12.5% of the cases which disappeared in the next 3--4 days. Gastrointestinal and skin bleedings were found in four cases (3.8%). Three patients (2.9%) had shock without dehydration.

Patients had signs of brainstem involvement such as----absent oculocephalic reflex (48.1%), symmetrical pupillary abnormalities (normal or dilated pupils with loss of light reflex in 43.3%) and respiratory irregularities (central hyperventilation, Biots breathing, intermittent prolonged inspiratory gasps) were found in 15.3%. There were no focal asymmetrical, neurological signs such as hemiplegia.

The results of routine haematological, biochemical and cerebrospinal fluid (CSF) analysis done in most of the cases were within reference range ([Table 1](#T1){ref-type="table"}) and no significant difference was observed among patients who survived from those who did not. The results of coagulogram which was done for four patients with bleeding manifestations suggested disseminated intravascular coagulopathy (DIC). CT scan (*n* = 5) and MRI of brain (*n* = 1) were essentially normal.

###### 

*Hematological and biochemical profile*

  Parameter                        Total tested   Mean (±2SD)               Reference range
  -------------------------------- -------------- ------------------------- ------------------------
  Hemoglobin                       83             11.09 (8.76--13.42)       11.5--15.5 gm/dl
  Neutrophils                      83             59.88 (50.79--68.97)      54--62%
  Lymphocytes                      83             32.01 (22.71--41.32)      25--33%
  Total leukocyte count (TLC)      83             8200 (3436--12963)        4500--11000 Cells/cumn
  Platelet count                   83             2.36 (1.37--3.36)         1.5--4 lakhs/cumm
  Serum sodium                     83             136.06 (127.36--144.76)   138--145 mmol/l
  Serum potassium                  83             4.14 (2.96--5.32)         3.5--5.0 mmol/l
  Blood urea                       83             18.58 (9.04--28.12)       7--18 mg/dl
  Serum Creatinine                 84             0.89 (0.57--1.21)         0.5--1 mg/dl
  Random blood sugar (RBS)         84             102.29 (62.61--141.96)    60--100 mg/dl
  Total serum bilirubin (TSB)      48             0.98 (0.75--1.21)         0.2--1 mg/dl
  SGPT                             48             22.40 (0--45.66)          5--45 U/l
  Alkaline phosphatase             47             279.23 (53.27--505.20)    145--420 U/l
  Serum Ammonia                    47             77.36 (41.96--112.76)     48--195 Microgram N/dl
  Cerebrospinal fluid protein      36             30.56 (12.4--48.71)       15--45 mg/dl
  Cerebrospinal fluid cell count   36             2.39 (0− 6.28)            0--5 cells/cumm

Sera of 86 patients were tested for anti-JE antibodies and sera of 72 patients were tested for anti-dengue IgM antibodies at Hyderabad and were found to be negative.

Thirty-three blood samples, eight throat swabs and four CSF samples were sent to NIV, Pune for virological and serological analysis. The viral studies included tissue culture using Vero, MDCK and RD cell lines, Peripheral blood co-cultures, Intra cerebral inoculation in 1-day-old Swiss albino mice and RT-PCR. The isolates were confirmed to be Chandipura (CHP) virus by electron microscopy, quick complement----fixation test using hyperimmune CHP virus antiserum, *in vitro* neutralization test in vero cells and RT-PCR.

CHP virus was isolated and confirmed in eight cases. In 14 cases, anti-CHP virus, IgM antibodies were detected ([Table 2](#T2){ref-type="table"}). In one case, both IgM antibodies and PCR were positive. All the samples tested negative for Japanese encephalitis, West Nile, dengue, measles, paramyxovirus, rabies, enterovirus, influenza, corona virus and also mycoplasma at three National Laboratories.

###### 

*Details of CHP viral studies*

  PT no   Age/sex   IgM   POD   IgG            NT      Isolation     PCR                    
  ------- --------- ----- ----- -------------- ------- ------------- ---------- ----- ----- -----
  1       5/M       −ve   1     −ve            \<10    V/R                      +ve         
  4       4/F       −ve   0     −ve            \<10                  +ve (PB)               
  5       4/F       −ve   2     −ve (SR/CSF)   \<10    +ve (V/R/M)   −ve (PB)   +ve   −ve   −ve
  7\*\*   6/F       −ve   1     −ve (SR/CSF)   5       −ve (V/R)     −ve (PB)         +ve   −ve
  8       2.5/F     −ve   2     −ve            \<10    −ve (V/R/M)   +ve (PB)   −ve   −ve   −ve
  9       9/F       +ve   8     −ve            270                                          
  10      11/F      +ve   7     −ve            \<10                                         
  11      4/M       +ve   7     +ve            \>270                                        
  12      4/F       +ve   14    +ve            \>270                                        
  13      8/M       +ve   0     +ve            \<10                                         
  14      9/M       −ve   1     −ve            \<10    +ve (M)                  +ve         
  15      11/F      +ve   12    +ve            \>270                                        
  16      4/M       +ve   10    +ve            270                                          
  17      9/M       +ve   7     −ve            90                                           
  18      5/F       +ve   6     −ve            10                                           
  19      0.75/M    +ve   6     +ve            \>270                                        
  20      3/F       +ve   5     +ve (SR/CSF)   270     −ve (V/R/M)              −ve         −ve
  23      4/M       +ve   7     +ve (SR/CSF)   90      −ve (V/R/M)   −ve (PB)   −ve   −ve   
  24      5/M       +ve   4     −ve            \<10                             +ve         
  25      4/F       +ve   8     +ve            \>270                                        
  32      8/F       −ve   0     −ve            5       −ve(V/R)      ND               +ve   NA

POD: Post Admission Day; PB: Peripheral blood Co-cultures; NT: Neutrilization test; ND: Not done; TS: Tissue culture; NA: Not available; BLD: Blood clot; V/R: Vero/RD; SR: Serum; V/R/M: Vero/RD/MDCK; CSF: Cerebrospinal fluid.

The clinical features of 21 cases (Group A) with CHP virus confirmation (culture/PCR/IgM antibodies) were compared with the remaining 83 cases (Group B) who either tested CHP negative or samples were not available for operational reasons ([Table 3](#T3){ref-type="table"}). The profile was similar in these two groups on detailed univariate analysis using SPSS software. It indicates possibility of same etiology in all these cases of encephalitis of this outbreak for the reasons----(i) negative viral isolation does not exclude viral infection of CNS \[[@B2]\]; (ii) positive antibody index is not reliably obtained until 1--2 weeks of neurological illness \[[@B2]\] and (iii) in general terms, an epidemic is caused by a single microbial agent. In this outbreak, no other etiological agent was detected.

###### 

*Comparing the clinical profile of CHP +ve cases (Group A) and others (Group B)*

  Clinical feature                       Group A (21) CHP   Group B (83)   *p* value   Chi-square   95% CI            OR
  -------------------------------------- ------------------ -------------- ----------- ------------ ----------------- -------
  Age                                                                                                                 
      ≤5 years                           10 (47.6%)         51 (61.4%)                                                
      \> 5 years                         11 (52.4%)         32 (38.6%)     0.250       1.321        0.669--4.596      1.753
  Sex                                                                                                                 
      Male                               09 (42.9%)         50 (60.2%)     0.151       2.063        0.188--1.305      0.495
      Female                             12 (57.1%)         33 (39.8%)                                                
  Nutrition                                                                                                           
      Normal                             09 (42.9%)         34 (41%)                                                  
      Malnutrition (\<3 centile, NCHS)   12 (57.1%)         49 (59%)       0.875       0.025        0.410--2.848      1.081
  Fever grade                                                                                                         
      High grade                         09 (42.9%)         34 (41%)       0.875       0.025        0.351--2.437      0.925
      Low or mod. Grade                  12 (57.1%)         49 (59%)                                                  
  Fever (duration)                                                                                                    
      ≤3 days                            17 (81%)           73 (88%)       0.401       0.705        0.480--6.141      1.718
      \>3 days                           04 (19%)           10 (12%)                                                  
  Seizure (type)                                                                                                      
      GTCS                               20 (95.2%)         60 (72.3%)     0.052       3.764        0.972 -- 60.459   7.667
      Focal                              01 (4.8%)          23 (27.7%)                                                
  Altered sensorium (duration)                                                                                        
      ≤1 day                             15 (71.4%)         71 (85.5%)     0.127       2.333        0.767--7.306      2.367
      \>1 day                            06 (28.6%)         12 (14.5%)                                                
  GIT symptoms                                                                                                        
      Absent                             09 (42.9%)         27 (32.5%)     0.374       0.790        0.242--1.711      0.643
      Present                            12 (57.1%)         56 (67.5%)                                                
  Skin rash                                                                                                           
      Absent                             19 (90.5%)         72 (86.7%)     0.644       0.213        0.141--3.376      0.689
      Present                            2 (9.5%)           11 (13.3%)                                                
  Bleeding tendencies                                                                                                 
      Absent                             20(95.2%)          80 (96.4%)     1.000       0.000        0.132--13.508     1.333
      Present                            01 (4.8%)          03 (3.6%)                                                 
  Shock                                                                                                               
      Absent                             20 (95.2%)         81 (97.6%)                                                
      Present                            01 (4.8%)          02 (2.4%)      0.565       0.331        0.175--23.463     2.025
  Pupils                                                                                                              
      Normal                             12 (57.1%)         47 (56.6%)     0.966       0.002        0.388--2.686      1.021
      Abnormal                           09 (42.9%)         36 (43.4%)                                                
  Occulo cephalic reflex                                                                                              
      Present                            13 (61.9%)         41 (49.4%)     0.305       1.050        0.625--4.436      1.665
      Absent                             08 (38.1%)         42 (50.6%)                                                
  Glasgow coma scale                                                                                                  
      ≤7                                 14 (66.7%)         54 (65.1%)     0.890       0.019        0.338--2.265      0.931
      \> 7                               07 (33.3%)         29 (34.9%)                                                
  Out come                                                                                                            
      Death                              10 (47.6%)         39 (47%)       0.959       0.003        0.374--2.543      0.975
      Recovery                           11 (52.4%)         44 (53%)                                                  

Evolution of illness from fever to death was rapid with high fatality 47.1% (49/104). Majority of deaths (65%) occurred within 24 h and few deaths (6.6%) after 72 h of illness. The survivors recovered without any neurological sequelae. Case management consisted of standard management protocol for encephalitis excluding steroids.

In the absence of signs of raised intracranial pressure, lateral and central brain herniation altered sensorium could be due to predominantly reticular activating system (RAS) involvement in the brain stem rather then extensive cerebral involvement \[[@B3]\]. It is also corroborated by the absence of focal neurological signs, persistent seizures and normal CT and MRI brain.

Cerebrospinal (CSF) pleocytosis was absent in these cases as was also observed in encephalitis due to rabies \[[@B4]\], small pox and influenza \[[@B2],[@B5]\], where it is assumed that the cell metabolism is destroyed because of the activity of pyrogenic and encephalotoxic viral proteins \[[@B2]\]. It could be surmised that a similar mechanism may be operating in Chandipura encephalitis.

By comparing the survived and death cases, it was observed that several clinical symptoms were significantly associated with mortality on bivariate analysis ([Table 4](#T4){ref-type="table"}). However only high-grade fever (OR = 4.32, CI = 1.23--15.23, *p* = 0.023), absent oculocephalic refex (OR = 0.089, CI = 0.026--0.305, *p* \< 0.001) and Glasgow coma score \<7 (OR = 0.151, CI = 0.029--0.8, *p* = 0.026) were found to be significantly predicting the mortality on the multiple logistic regression analysing using SPSS for Windows.

###### 

*Bivariate analysis of clinical profile*

  Variable                   Death/Total (%)   OR         95% Cl          *p*-value
  -------------------------- ----------------- ---------- --------------- -----------
  Fever grade                                                             
      Low to mod             21/61 (34.4)      1          1.566--8.071    0.002
      High                   28/43 (65.1)      3.555                      
  Fever days                                                              
      \>3                    3/14 (21.4)       1          1.002--14.66    0.05
      ≤3                     46/90 (51.1)      3.833                      
  Seizure (type)                                                          
      Focal                  14/24 (58.3)      1          0.221--1.40     0.212
      GTCS                   35/80 (43.7)      0.556                      
  Altered Sensorium (days)                                                
      ≤1                     46/86 (53.5)      1          0.047--0.645    0.009
      \>1                    3/18 (16.7)       0.174                      
  Oculocephalic Reflex                                                    
      Absent                 37/50 (74.0)      1          0.041--0.247    \<0.001
      Present                12/54 (22.2)      0.10                       
  GIT symptoms                                                            
      Absent                 12/36 (33.3)      1          1.029--5.536    0.043
      Present                37/68 (54.4)      2.387                      
  Skin rash                                                               
      Absent                 46/91 (50.5)      1          0.076--1.137    0.076
      Present                3/13 (23.1)       0.293                      
  Bleeding tendencies                                                     
      Absent                 45/100            1          0--1.610        0.686
      Present                4/4 (100)         1639.89                    
  Pupils                                                                  
      Normal                 17/59 (28.8)      1          2.583--14.316   \<0.001
      Abnormal               32/45 (71.1)      6.081                      
  Shock                                                                   
      Absent                 45/101 (45.5)     1          0--1.710        0.727
      Present                3/3 (100)         1604.244                   
  Glasgow coma Score                                                      
      ≤7                     44/68 (64.7)      1          0.030--0.256    \<0.001
      \>7                    5/36 (31.9)       0.088                      
  Vomiting                                                                
      Absent                 15/42 (35.7)      1          0.977--4.890    0.057
      Present                34/62 (54.8)      2.186                      
  Diarrohea                                                               
      Absent                 27/65 (40.9)      1          0.884--4.463    0.097
      Present                22/38 (57.9)      1.986                      
  Malnutrition                                                            
      Absent                 19/43 (44.2)      1          0.558--2.677    0.616
      Present                30/61 (49.2)      1.222                      
  Respiration                                                             
      Regular                36/88 (40.9)      1          1.663--23.555   0.007
      Irregular              13/16 (81.3)      6.259                      

Signs and symptoms like pupillary abnormalities (absent light reflex with normal/dilated pupils), respiratory abnormalities (central hyperventilation, apneustic, ataxic respirations), absence of oculocephalic reflex and Glasgow coma score (\<7) suggested brainstem involvement and were found to be significantly contributing to high mortality. Some of these brainstem signs could be due to raised intracranial tension and brain herniation. But features suggestive of raised intracranial tension such as persistent and projectile vomiting, papilledema, bradycardia and hypertension were absent. Features suggestive of lateral and central herniation signs were also absent. All these observations indicated predominant involvement of brainstem due to viral tropism.

The clinical profile of this outbreak was different from JE in that clinical course was shorter, progression to death was rapid as compared to JE. Although seizures did occur in the initial phase of illness, they were few in number and could promptly be controlled unlike in JE;signs of extrapyramidal involvement characteristic of JE were absent and there was no meningeal involvement; there were no neurological sequelae in the recovered patients \[[@B6]\]; JE virus was not detected in this outbreak either on serology or PCR.

Encephalitis is an unusual manifestation of dengue fever which may occur late in the course of disease \[[@B7]\] unlike in the present epidemic where fever and altered sensorium occurred simultaneously. The presence of bleeding tendencies in four patients and shock in three patients was due to disseminated intravascular coagulopathy (DIC). The shock could also be due to involvement of vasomotor centre in the brainstem. Dengue etiology was ruled out serologically and virologically.

Reye syndrome is characterized by biphasic course, absence of fever, moderate hepatomegaly, abnormal liver function tests, hyperammonemia, hypoglycaemia \[[@B8]\]. In the present outbreak, all the cases had fever, none showed hepatomegaly or biochemical abnormalities ([Table 1](#T1){ref-type="table"}).

Thus the clinical profile of 2003 epidemic of encephalitis in A.P., India was quite different from the ones reported earlier \[[@B6], [@B8], [@B10]\]. It is characterized by rapid evolution of signs and symptoms with brainstem involvement leading to high mortality and absence of pleocytosis in CSF. CHP virus was the only etiological agent detected in this outbreak. However, further investigations are needed for broader understanding of pathogenesis and clinical spectrum of the disease should such an unfortunate episode recur.
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